Research graph
References from Remibrutinib as a Therapeutic Option for Solar Urticaria. Local targets link to admitted publications; unresolved targets remain external evidence.
Pathogenesis of Solar Urticaria: Classic Perspectives and Emerging Concepts
10.1111/exd.14493 · 2022 · External reference
Efficacy of Therapies for Solar Urticaria: A Systematic Review and Meta‐Analysis
10.3390/jcm14165736 · 2025 · External reference
Efficacy, Safety, and Quality‐Of‐Life Outcomes of Remibrutinib in Chronic Spontaneous Urticaria: A Systematic Review and Meta‐Analysis
2025 · External reference
BTK Signaling—A Crucial Link in the Pathophysiology of Chronic Spontaneous Urticaria
10.1016/j.jaci.2023.12.008 · 2024 · External reference
Remibrutinib in Chronic Spontaneous Urticaria: 52‐Week Results From Two Phase 3 Studies
10.1016/j.jaci.2025.09.028 · 2026 · External reference
Dupilumab in Patients With Chronic Spontaneous Urticaria
10.1001/jamadermatol.2025.6023 · 2026 · External reference
Solar Urticaria Successfully Treated With Remibrutinib
2026 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
